Morgan Stanley’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

Morgan Stanley’s Portfolio MKD Stock Details MKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-953	Closed	-$1K	–	8216
2022 Q2	$1K	Hold	953	–	–	﹤0.01%	7759
2022 Q1	$3K	Hold	953	–	–	﹤0.01%	7717
2021 Q4	$3K	Hold	953	–	–	﹤0.01%	7771
2021 Q3	$5K	Hold	953	–	–	﹤0.01%	7517
2021 Q2	$13K	Hold	953	–	–	﹤0.01%	7170
2021 Q1	$15K	Buy	+953	New	+$17.8K	﹤0.01%	6828

Other funds holding MKD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Morgan Stanley's MKD Position: Q3 2022 in Review

Morgan Stanley sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q3 2022, closing a stake of 953 shares — an estimated $1K sold.

Morgan Stanley first reported a position in MKD in Q1 2021 and held it in 6 quarters. The position peaked at $15K in Q1 2021. 2 funds tracked by Wall St. Rank hold MKD as of Q3 2022.

Morgan Stanley reported no remaining Molecular Data Inc. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Morgan Stanley sold 953 Molecular Data Inc. American Depositary Shares shares in Q3 2022, an estimated $1K.
Morgan Stanley first reported a position in Molecular Data Inc. American Depositary Shares in Q1 2021 and held it in 6 quarters.
Morgan Stanley's Molecular Data Inc. American Depositary Shares position peaked at $15K in Q1 2021.
2 funds tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.